Bio­gen lays off more em­ploy­ees af­ter re­duc­ing head­count last year

Bio­gen con­firmed to End­points News it has re­cent­ly told “some” of its US work­ers that they would be laid off.

A spokesper­son de­clined to say how many em­ploy­ees or the types of roles in­volved. The unit main­ly af­fect­ed was the mul­ti­ple scle­ro­sis team, per a Mon­day morn­ing re­port in the Boston Busi­ness Jour­nal.

The staff re­duc­tion is a “re­sult of de­ci­sions de­signed to op­ti­mize our busi­ness strate­gies and align our cost and rev­enue base,” the spokesper­son said, adding that the im­pact­ed em­ploy­ees can get sev­er­ance and sup­port ser­vices, and can ap­ply for po­si­tions else­where with­in the com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER